ORE Pharmaceuticals INC.
SEC CIK 1043914 · ORXE.PK · last insider filing 2010-11-05
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Howard Jack L | Director | filed 2010 - 2010 |
| Kong Kenneth | Director | filed 2010 - 2010 |
| Gabrielson Mark J | Director · Chief Executive Officer | filed 2007 - 2009 |
| Fordyce James W | Director | filed 2009 - 2009 |
| Gorry G Anthony PHD | Director | filed 2006 - 2009 |
| Thompson J Stark PHD | Director | filed 2006 - 2009 |
| Urdal David | Director | filed 2007 - 2009 |
| Gessler Mark D | Director · CEO and President | filed 2007 - 2008 |
| Dimmler Charles L III | Director · CEO & President | filed 2006 - 2008 |
| Miller Lloyd I III | Director | filed 2006 - 2008 |
| Douglas Frank L | Director | filed 2006 - 2007 |
| Brennan Michael J | Director | filed 2007 - 2007 |
| Blake Jules PHD | Director | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Gibson Terry | CEO and CFO | filed 2010 - 2010 |
| Palleiko Benjamin L | SVP & Chief Financial Officer | filed 2009 - 2010 |
| Donahue Stephen R | Senior Vice President | filed 2009 - 2010 |
| Dunne Chris T | Principal Accounting Officer | filed 2009 - 2009 |
| Rohrer Philip L JR | Chief Financial Officer | filed 2007 - 2008 |
| Staples F Dudley JR | Senior VP, Secretary | filed 2007 - 2008 |
| Tiffany Larry M | SVP & Interim GM Gemonics | filed 2006 - 2008 |
| Tartaglia Louis A | SVP & GM Drug Repositioning | filed 2006 - 2007 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.